title: Effect of Ottoman Viper (Montivipera xanthina (Gray, 1849)) Venom on Various Cancer Cells and on Microorganisms.
abstract: Cytotoxic and antimicrobial effects of Montivipera xanthina venom against LNCaP, MCF-7, HT-29, Saos-2, Hep3B, Vero cells and antimicrobial activity against selected bacterial and fungal species: Staphylococcus aureus ATCC 25923, Escherichia coli ATCC 25922, E. coli O157H7, Enterococcus faecalis 29212, Enterococcus faecium DSM 13590, Staphylococcus epidermidis ATCC 12228, S. typhimirium CCM 5445, Proteus vulgaris ATCC 6957 and Candida albicans ATCC 10239 were studied for evaluating the potential medical benefit of this snake venom. Cytotoxicity of venom was determined using MTT assay. Snake venom cytotoxicity was expressed as the venom dose that killed 50 % of the cells (IC50). The antimicrobial activity of venom was studied by minimal inhibitory concentration (MIC) and disc diffusion assay. MIC was determined using broth dilution method. The estimated IC50 values of venom varied from 3.8 to 12.7 or from 1.9 to 7.2 μg/ml after treatment with crude venom for 24 or 48 h for LNCaP, MCF-7, HT-29 and Saos-2 cells. There was no observable cytotoxic effect on Hep3B and Vero cells. Venom exhibited the most potent activity against C. albicans (MIC, 7.8 μg/ml and minimal fungicidal concentration, 62.5 μg/ml) and S. aureus (MIC, 31.25 μg/ml). This study is the first report showing the potential of M. xanthina venom as an alternative therapeutic approach due to its cytotoxic and antimicrobial effects.
authors: Department of Biology, Basic and Industrial Microbiology Section, Faculty of Science, Ege University, 35100, Bornova, Izmir, Turkey, tansel.yalcin@ege.edu.tr.
authors: Husniye Tansel
authors: HT
authors: Yalcın
authors: Mehmet Ozgün
authors: MO
authors: Ozen
authors: Bayram
authors: B
authors: Gocmen
authors: Ayse
authors: A
authors: Nalbantsoy
references: Ann Clin Microbiol Antimicrob. 2009 May 18;8:16
references: 19450272
references: Cell Mol Life Sci. 2006 Dec;63(24):3030-41
references: 17103111
references: Am J Clin Pathol. 1966 Apr;45(4):493-6
references: 5325707
references: J Immunol Methods. 1983 Dec 16;65(1-2):55-63
references: 6606682
references: Toxicon. 2012 Sep 15;60(4):648-55
references: 22781133
references: J Appl Microbiol. 2007 Mar;102(3):650-9
references: 17309613
references: Biochem J. 2007 Feb 15;402(1):93-104
references: 17044815
references: Curr Cancer Drug Targets. 2009 May;9(3):307-19
references: 19442051
references: Haemostasis. 2001 May-Dec;31(3-6):183-91
references: 11910184
references: Indian J Exp Biol. 2002 Dec;40(12):1353-8
references: 12974396
references: Cancer. 1974 Aug;34(2):239-45
references: 4852055
references: Acta Microbiol Immunol Hung. 2007 Sep;54(3):201-35
references: 17896473
references: BMC Infect Dis. 2006 Jun 20;6:100
references: 16784542
references: Anal Biochem. 1976 May 7;72:248-54
references: 942051
references: Mol Cancer Ther. 2004 Apr;3(4):499-511
references: 15078994
references: Oncogene. 2003 Oct 20;22(47):7414-30
references: 14576849
references: Angiogenesis. 1999;3(3):259-69
references: 14517425
references: Eur J Cancer. 1978 Jun;14(6):707-12
references: 658095